Details

At KSGD, Illumina will sponsor for luncheon seminar, booth, book ads and homepage banner as gold sponsorship. Attend the Illumina Luncheon seminar from Dr Myung shin Kim to learn about the overview of genetic testing, pros and cons of each testing as a clinical testing, and future direction.

At the Illumina booth, we will introduce how whole genome sequencing and whole exome sequencing are used in genetic disease testing and how comprehensive NGS promotes efficiencies in genetic disease analysis. Please visit Illumina Booth to learn more about.

Luncheon Seminar
Date & Time: Jun 10
Venue: Yongsan Dragon City Hotel
Speaker: Myungshin Kim (Dept. Laboratory Medicine, College of Medicine, Catholic University)
Talk title: Improved diagnosis of various rare diseases: beyond gene panel
Abstract: A rare disease is defined as a condition that affects fewer than 20,000 people in Korea. This definition was created by Rare disease management act of 2015. It has been known that over 70% of rare diseases are known to be genetic. Although rare diseases became known as orphan diseases because drug companies were not interested in adopting them to develop treatments, recent advances in genetic testing, especially next generation sequencing technologies (NGS), have improved the genetic diagnosis of rare disease.
There is no doubt that a positive genetic diagnosis could provide further information to aid clinical decisions and patient management. However, it should be addressed what sequencing method is the most efficient for identifying genes driving each rare disease. This talk is the first, to present an overview of genetic testing from Sanger sequencing to whole genome sequencing. Then, I review the pros and cons of each testing as a clinical testing. Finally, I would like to discuss the future direction of genetic testing.
Date & Time
9 Jun. 2022 – 10 Jun. 2022
Location
Seoul Dragon City Hotel
Korea South
Asia
Topic
Genetic & Rare Diseases